NCT03401801

Brief Summary

The purpose of this study was to compare the temperature changes of the upper extremities when using local anesthetic of various volume (4ml, 6ml, 8ml) in the ultrasound guided stellate ganglion block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 21, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 4, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 17, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2018

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
Last Updated

June 25, 2019

Status Verified

June 1, 2019

Enrollment Period

8 months

First QC Date

January 4, 2018

Last Update Submit

June 23, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Temperature change(°C) in ipsilateral arm

    Temperature is measured with a laser thermometer on the palmar aspect of 3 cm below from the middle finger.

    thirty minute after US-guided SGB

Secondary Outcomes (9)

  • Temperature changes(°C) in ipsilateral arm

    10 and 20 min after US-guided SGB

  • Temperature changes in ipsilateral face

    10, 20, and 30 min after US-guided SGB

  • Temperature changes in contralateral face

    10, 20, and 30 min after US-guided SGB

  • Temperature changes in ipsilateral medial elbow

    10, 20, and 30 min after US-guided SGB

  • Temperature changes in contralateral medial elbow

    10, 20, and 30 min after US-guided SGB

  • +4 more secondary outcomes

Study Arms (3)

4 ml of 1% lidocaine

ACTIVE COMPARATOR

Procedure: 4 ml of 1% lidocaine is injected for stellate ganglion block using the Ultrasound(US)-guided lateral approach at the sixth cervical vertebral level.

Procedure: Stellate ganglion block

6 ml of 1% lidocaine

ACTIVE COMPARATOR

Procedure: 6 ml of 1% lidocaine is injected for stellate ganglion block using the US-guided lateral approach at the sixth cervical vertebral level.

Procedure: Stellate ganglion block

8 ml of 1% lidocaine

ACTIVE COMPARATOR

Procedure: 8 ml of 1% lidocaine is injected for stellate ganglion block using the US-guided lateral approach at the sixth cervical vertebral level.

Procedure: Stellate ganglion block

Interventions

Well trained pain physician performs all the ultrasound(US)-guided stellate ganglion block(SGB)s, who is not involved in evaluating study variables. Electrocardiography, noninvasive blood pressure, heart rate, and peripheral oxygen saturation were monitored for all patients before, while, and after conducting procedure. For US-guided SGB, patients are supine positioned, and skin preparation on injection site is done with chlorohexidine. Procedure is conducted under ultrasound guidance at C6 level. 4 ml, 6 ml, and 8 ml of 1% lidocaine is injected for the each group, respectively.

4 ml of 1% lidocaine6 ml of 1% lidocaine8 ml of 1% lidocaine

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 to 85 years
  • Patients with a new or known diagnosis of chronic neuropathic pain at the upper extremity or face.

You may not qualify if:

  • Refusal of a patient
  • Any vascular disease in the upper extremities (or face)
  • Previous history of thoracic sympathetic or stellate ganglion neurolysis (e.g. thermocoagulation, radiofrequency neuromodulation, and/or chemical neurolysis)
  • Coagulopathy
  • Systemic infection or local infection at the needle injection site
  • Major deformation at the level of the neck (radiotherapy, surgery, etc.)
  • Concomitant chronic pain syndrome at other sites.
  • Post-pneumonectomy on the controlateral side
  • Known allergy to local anesthetics of amide type
  • Inability to understand a numeric rating pain scale (cognitive dysfunction)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

Related Publications (4)

  • Kapral S, Krafft P, Gosch M, Fleischmann D, Weinstabl C. Ultrasound imaging for stellate ganglion block: direct visualization of puncture site and local anesthetic spread. A pilot study. Reg Anesth. 1995 Jul-Aug;20(4):323-8.

    PMID: 7577781BACKGROUND
  • Schurmann M, Gradl G, Wizgal I, Tutic M, Moser C, Azad S, Beyer A. Clinical and physiologic evaluation of stellate ganglion blockade for complex regional pain syndrome type I. Clin J Pain. 2001 Mar;17(1):94-100. doi: 10.1097/00002508-200103000-00012.

    PMID: 11289093BACKGROUND
  • Jung G, Kim BS, Shin KB, Park KB, Kim SY, Song SO. The optimal volume of 0.2% ropivacaine required for an ultrasound-guided stellate ganglion block. Korean J Anesthesiol. 2011 Mar;60(3):179-84. doi: 10.4097/kjae.2011.60.3.179. Epub 2011 Mar 30.

  • Stevens RA, Stotz A, Kao TC, Powar M, Burgess S, Kleinman B. The relative increase in skin temperature after stellate ganglion block is predictive of a complete sympathectomy of the hand. Reg Anesth Pain Med. 1998 May-Jun;23(3):266-70. doi: 10.1016/s1098-7339(98)90053-0.

MeSH Terms

Conditions

Neuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jee Youn Moon, MD, PhD

    Seoul National University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

January 4, 2018

First Posted

January 17, 2018

Study Start

November 21, 2017

Primary Completion

July 21, 2018

Study Completion

July 31, 2018

Last Updated

June 25, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations